Physician profile
Douglas W Dothager
NPI 1871599738
$11,717.75
in general payments reported to CMS, 2019-2025
44 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,400 · 2020: $851 · 2021: $1,370 · 2022: $1,746 · 2023: $2,936 · 2024: $2,402 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,308 · Education: $42.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,307.56 |
| Education | $42.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,395.98 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $2,023.14 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Jazz Pharmaceuticals INC. | $813.03 | 2019-2025 | Xywav |
| Boehringer Ingelheim Pharmaceuticals, INC. | $720.53 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Electromed, INC. | $610.55 | 2019-2024 | Smartvest |
| Genzyme Corporation | $595.33 | 2021-2025 | |
| Harmony Biosciences LLC | $472.57 | 2022-2024 | Wakix |
| Regeneron Healthcare Solutions, INC. | $410.24 | 2023-2025 | Dupixent |
| Insmed, INC. | $385.69 | 2019-2025 | Arikayce |
| Axsome Therapeutics, INC. | $292.45 | 2022-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $253.76 | 2020-2024 | Glassia |
| Grifols USA, LLC | $244.57 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $239.39 | 2019-2025 | Zerbaxa, Recarbrio |
| Avadel Cns Pharmaceuticals, LLC | $197.21 | 2024-2025 | Lumryz |
| Resmed Corp | $180.10 | 2019-2024 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $175.74 | 2019-2020 | |
| Philips North America LLC | $145.86 | 2019-2023 | |
| Baxter Healthcare | $141.75 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $123.74 | 2019-2024 | Yupelri |
| Inspire Medical Systems, INC. | $118.28 | 2023-2025 | Inspire |
| Vanda Pharmaceuticals INC. | $113.22 | 2020-2021 | |
| United Therapeutics Corporation | $109.96 | 2024 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $102.93 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $94.73 | 2023-2024 | Opsumit, Uptravi |
| Shionogi INC | $89.18 | 2024-2025 | Fetroja |
| Shire North American Group INC | $82.25 | 2019 | |
| Pfizer INC. | $70.63 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $61.52 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $61.09 | 2022-2023 | Quviviq |
| Eisai INC. | $54.90 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $49.72 | 2019-2022 | |
| Circassia INC. | $43.42 | 2019-2020 | |
| Genentech USA, INC. | $30.05 | 2019 | |
| Veran Medical Technologies, INC. | $27.78 | 2019 | |
| Ge Healthcare | $25.97 | 2023 | |
| Amgen INC. | $24.94 | 2023 | Tezspire |
| Hologic Sales and Service, LLC | $22.33 | 2024 | Thinprep 2000 Processor, Aptima, Third Wave |
| La Jolla Pharmaceutical Company | $21.80 | 2025 | |
| Lilly USA, LLC | $20.35 | 2025 | Zepbound |
| Viatris Specialty LLC | $18.17 | 2025 | Yupelri |
| Advanced Respiratory, INC | $14.20 | 2019 | |
| Fisher & Paykel Healthcare INC | $13.90 | 2023 | Fisher & Paykel Healthcare |
| Allergan, INC. | $13.77 | 2019 | |
| Itamar Medical INC | $11.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Dothager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.